drugset / Trial / NCT01611415

Drug to Drug Interaction Study With Ipragliflozin and Furosemide

NCT01611415

Phase 1 Completed 24 enrolled Astellas Pharma Europe B.V.
RandomizedCrossoverOpen-labelBasic science

Summary

A study to investigate if there are any pharmacodynamic and pharmacokinetic interactions between furosemide and ipragliflozin (ASP1941) in healthy volunteers.

Timeline

Start
2011-07
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified Oral
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.